580
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension—preliminary results

, , , , , & show all
Pages 249-252 | Received 31 Mar 2010, Accepted 16 Apr 2010, Published online: 22 Sep 2010

References

  • Chobanian AV, Alexander RW. Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. Arch Intern Med. 1996;156:1952–6.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–52.
  • Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin binding sites in bovine and human retinal blood vessels. Invest Ophthalmol Vis Sci. 1987;28:1747–51.
  • Ferrari-Dileo G, Davis EB, Anderson DR. Angiotensin II binding receptors in retinal and optic nerve head blood vessels. An autoradiographic approach. Invest Ophthalmol Vis Sci. 1991;32:21–6.
  • Ward PE, Stewart TA, Hammon KJ, Reynolds RC, Igic RP. Angiotensin I converting enzyme (kininase II) in isolated retinal microvessels. Life Sci. 1979;24:1419–24.
  • Elena PP, Kosina-Boix M, Moulin G, Lapalus P. Autoradiographic localization of beta-adrenergic receptors in rabbit eye. Invest Ophthalmol Vis Sci. 1987;28:1436–41.
  • Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. Hypertensive optic neuropathy. Ophthalmology. 1986;93:74–87.
  • Steigerwalt RD, Belcaro GV, Laurora G, Cesarone MR, De Sanctis MT, Incandela L. Ocular and orbital blood flow in patients with essential hypertension treated with trandolapril. Retina. 1998;18:539–45.
  • Kutschbach P, Wolf S, Cremer S, Toonen F, Reim M. [Effect of different single agent antihypertensive therapies on peri-foveal microcirculation in patients with arterial hypertension]. Ophthalmologe. 1996;93:699–702 (in German).
  • Delles C, Michelson G, Harazny J, Oehmer S, Hilgers KF, Schmieder RE. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke. 2004;35:1289–93.
  • Ahmetoğlu A, Erdöl H, Simşek A, Gökçe M, Dinç H, Gümele HR. Effect of hypertension and candesartan on the blood flow velocity of the extraocular vessels in hypertensive patients. Eur J Ultrasound. 2003;16:177–82.
  • Oehmer S, Harazny J, Delles C, Schwarz T, Handrock R, Michelson G, Valsartan and retinal endothelial function in elderly hypertensive patients. Blood Press. 2006;15:185–91.
  • Schocket LS, Grunwald JE, Dupont J. Effect of oral felodipine on ocular circulation. Int Ophthalmol. 1999;23:79–84.
  • Puddu P, Puddu GM, Cravero E, Muscari A. Different effects of antihypertensive drugs on endothelial dysfunction. Acta Cardiol. 2004;59:555–64.
  • Schiffrin EL. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers. Can J Cardiol. 2002;18(A):15A–18A.
  • Ferrari-Dileo G. Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels. Invest Ophthalmol Vis Sci. 1988;29:695–9.
  • Kahle G, Kaulen P, Wollensak J. Quantitative autoradiography of beta-adrenergic receptors in rabbit eyes. Exp Eye Res. 1990;51:503–7.
  • Opie LH, Yusuf S. Beta blocking agents. In: Opie LH, editor. Drugs for the heart. Philadelphia: WB Saunders; 2001. p. 1–32.
  • Prichard BNC, Cruickshank JM, Graham B. Beta-blockers in the third millennium—when are they really indicated. J Clin Basic Cardiol. 2001;4:3–9.